Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity.
Boutari C, Stefanakis K, Simati S, Guatibonza-García V, Valenzuela-Vallejo L, Anastasiou IA, Connelly MA, Kokkinos A, Mantzoros CS. Boutari C, et al. Among authors: guatibonza garcia v. Cardiovasc Diabetol. 2024 May 18;23(1):174. doi: 10.1186/s12933-024-02264-5. Cardiovasc Diabetol. 2024. PMID: 38762719 Free PMC article.
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.
Valenzuela-Vallejo L, Chrysafi P, Kouvari M, Guatibonza-Garcia V, Mylonakis SC, Katsarou A, Verrastro O, Markakis G, Eslam M, Papatheodoridis G, Mingrone G, George J, Mantzoros CS. Valenzuela-Vallejo L, et al. Among authors: guatibonza garcia v. Metabolism. 2023 Nov;148:155694. doi: 10.1016/j.metabol.2023.155694. Epub 2023 Sep 25. Metabolism. 2023. PMID: 37757973
The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study.
Kouvari M, Mylonakis SC, Katsarou A, Valenzuela-Vallejo L, Guatibonza-Garcia V, Kokkorakis M, Verrastro O, Angelini G, Markakis G, Eslam M, George J, Papatheodoridis G, Mingrone G, Mantzoros CS. Kouvari M, et al. Among authors: guatibonza garcia v. Diabetes Res Clin Pract. 2023 Sep;203:110870. doi: 10.1016/j.diabres.2023.110870. Epub 2023 Aug 9. Diabetes Res Clin Pract. 2023. PMID: 37567510
Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study.
Kouvari M, Valenzuela-Vallejo L, Guatibonza-Garcia V, Polyzos SA, Deng Y, Kokkorakis M, Agraz M, Mylonakis SC, Katsarou A, Verrastro O, Markakis G, Eslam M, Papatheodoridis G, George J, Mingrone G, Mantzoros CS. Kouvari M, et al. Among authors: guatibonza garcia v. Metabolism. 2023 Oct;147:155666. doi: 10.1016/j.metabol.2023.155666. Epub 2023 Jul 30. Metabolism. 2023. PMID: 37527759
Impact of metabolic control on all-cause mortality in a nationwide cohort of patients with diabetes from Colombia.
Mendivil CO, Amaya-Montoya M, Hernández-Vargas JA, Ramírez-García N, Herrera-Parra LJ, Guatibonza-García V, Romero-Díaz C, Pérez-Londoño A, Acuña-Merchán L. Mendivil CO, et al. Among authors: guatibonza garcia v. Front Endocrinol (Lausanne). 2023 Jan 19;14:1073833. doi: 10.3389/fendo.2023.1073833. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742410 Free PMC article.
Achievement of treatment goals among adults with diabetes in Colombia, 2015-2019: Results from a national registry.
Mendivil CO, Amaya-Montoya M, Hernández-Vargas JA, Ramírez-García N, Romero-Díaz C, Pérez-Londoño A, Guatibonza-García V, Acuña-Merchán L. Mendivil CO, et al. Among authors: guatibonza garcia v. Diabetes Res Clin Pract. 2022 Apr;186:109823. doi: 10.1016/j.diabres.2022.109823. Epub 2022 Mar 7. Diabetes Res Clin Pract. 2022. PMID: 35271878
11 results